BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee SR, Kardos KW, Schiff E, Berne CA, Mounzer K, Banks AT, Tatum HA, Friel TJ, Demicco MP, Lee WM, Eder SE, Monto A, Yearwood GD, Guillon GB, Kurtz LA, Fischl M, Unangst JL, Kriebel L, Feiss G, Roehler M. Evaluation of a new, rapid test for detecting HCV infection, suitable for use with blood or oral fluid. Journal of Virological Methods 2011;172:27-31. [DOI: 10.1016/j.jviromet.2010.12.009] [Cited by in Crossref: 71] [Cited by in F6Publishing: 69] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 AASLD/IDSA HCV Guidance Panel. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus: HEPATITIS C VIRUS GUIDANCE PANEL. Hepatology 2015;62:932-54. [DOI: 10.1002/hep.27950] [Cited by in Crossref: 844] [Cited by in F6Publishing: 832] [Article Influence: 120.6] [Reference Citation Analysis]
2 Jewett A, Al-Tayyib AA, Ginnett L, Smith BD. Successful Integration of Hepatitis C Virus Point-of-Care Tests into the Denver Metro Health Clinic. AIDS Res Treat 2013;2013:528904. [PMID: 24455220 DOI: 10.1155/2013/528904] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
3 Crowley D, Murtagh R, Cullen W, Keevans M, Laird E, McHugh T, McKiernan S, Miggin SJ, O'Connor E, O'Reilly D, Betts-Symonds G, Tobin C, Van Hout MC, Lambert JS. Evaluating peer-supported screening as a hepatitis C case-finding model in prisoners. Harm Reduct J. 2019;16:42. [PMID: 31277665 DOI: 10.1186/s12954-019-0313-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
4 Malon RS, Sadir S, Balakrishnan M, Córcoles EP. Saliva-based biosensors: noninvasive monitoring tool for clinical diagnostics. Biomed Res Int 2014;2014:962903. [PMID: 25276835 DOI: 10.1155/2014/962903] [Cited by in Crossref: 75] [Cited by in F6Publishing: 46] [Article Influence: 9.4] [Reference Citation Analysis]
5 Staton M, Strickland JC, Webster JM, Leukefeld C, Oser C, Pike E. HIV Prevention in Rural Appalachian Jails: Implications for Re-entry Risk Reduction Among Women Who Use Drugs. AIDS Behav 2018;22:4009-18. [PMID: 29959722 DOI: 10.1007/s10461-018-2209-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
6 Chionne P, Madonna E, Villano U, Tritarelli E, Pisani G, Costantino A, Equestre M, Marcantonio C, Bruni R, Ciccaglione AR. Sensitivity of hepatitis C virus rapid tests in detecting antibodies in general population. Panminerva Med 2020;62:125-30. [PMID: 31692308 DOI: 10.23736/S0031-0808.19.03678-4] [Reference Citation Analysis]
7 Salek TP, Katz AR, Lenze SM, Lusk HM, Li D, Des Jarlais DC. Seroprevalence of HCV and HIV infection among clients of the nation's longest-standing statewide syringe exchange program: A cross-sectional study of Community Health Outreach Work to Prevent AIDS (CHOW). Int J Drug Policy 2017;48:34-43. [PMID: 28779632 DOI: 10.1016/j.drugpo.2017.06.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
8 Loggi E, Vukotic R, Conti F, Gitto S, Andreone P. Gold standard assays for the monitoring of patients with chronic hepatitis C. Future Virology 2018;13:529-37. [DOI: 10.2217/fvl-2018-0032] [Reference Citation Analysis]
9 Mahajan S, Agarwal R, Rawat V, Kumar G, Sharma MK, Gupta E. Comparative evaluation of three rapid immunochromatographic test assays with chemiluminescent microparticle immunoassay for the detection of hepatitis C virus antibody. Virusdisease 2019;30:373-9. [PMID: 31803804 DOI: 10.1007/s13337-019-00542-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
10 Smith BD, Jewett A, Drobeniuc J, Kamili S. Rapid diagnostic HCV antibody assays. Antivir Ther 2012;17:1409-13. [PMID: 23322678 DOI: 10.3851/IMP2470] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
11 O'connell RJ, Gates RG, Bautista CT, Imbach M, Eggleston JC, Beardsley SG, Manak MM, Gonzales R, Rentas FJ, Macdonald VW, Cardo LJ, Reiber DT, Stramer SL, Michael NL, Peel SA. Laboratory evaluation of rapid test kits to detect hepatitis C antibody for use in predonation screening in emergency settings: HCV RAPID TESTS FOR PREDONATION SCREEN. Transfusion 2013;53:505-17. [DOI: 10.1111/j.1537-2995.2012.03770.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
12 Witkowska McConnell W, Davis C, Sabir SR, Garrett A, Bradley-Stewart A, Jajesniak P, Reboud J, Xu G, Yang Z, Gunson R, Thomson EC, Cooper JM. Paper microfluidic implementation of loop mediated isothermal amplification for early diagnosis of hepatitis C virus. Nat Commun 2021;12:6994. [PMID: 34848705 DOI: 10.1038/s41467-021-27076-z] [Reference Citation Analysis]
13 Mack CL, Gonzalez-Peralta RP, Gupta N, Leung D, Narkewicz MR, Roberts EA, Rosenthal P, Schwarz KB;  North American Society for Pediatric Gastroenterology; Hepatology, and Nutrition. NASPGHAN practice guidelines: Diagnosis and management of hepatitis C infection in infants, children, and adolescents. J Pediatr Gastroenterol Nutr. 2012;54:838-855. [PMID: 22487950 DOI: 10.1097/mpg.0b013e318258328d] [Cited by in Crossref: 134] [Cited by in F6Publishing: 46] [Article Influence: 13.4] [Reference Citation Analysis]
14 Post JJ, Arain A, Lloyd AR. Enhancing assessment and treatment of hepatitis C in the custodial setting. Clin Infect Dis. 2013;57 Suppl 2:S70-S74. [PMID: 23884069 DOI: 10.1093/cid/cit265] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.8] [Reference Citation Analysis]
15 Cottone C, Bhamidimarri KR. Evaluating CKD/ESRD patient with hepatitis C infection: How to interpret diagnostic testing and assess liver injury. Semin Dial 2019;32:119-26. [PMID: 30599462 DOI: 10.1111/sdi.12760] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Lee S, Maccullough C, Chan M, Leib J, Davis C, Jacobson J. Salivary Diagnostics – A New Industry: Perspectives from Business Development, Government, Regulatory, and Payers. Adv Dent Res 2011;23:369-74. [DOI: 10.1177/0022034511420437] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
17 López-Osorio MC, Beltrán M, Navas MC. [Epidemiology of hepatitis C virus infection in ColombiaEpidemiologia da infecção pelo vírus da hepatite C na Colômbia]. Rev Panam Salud Publica 2021;45:e96. [PMID: 34539763 DOI: 10.26633/RPSP.2021.96] [Reference Citation Analysis]
18 Yang RF, Liu Y, Zhao CY, Ding YX, Chen Y, Wang YD, Duan ZP. A novel point-of-care oral anti-HCV assay: Is it reliable for screening hepatitis C virus infection in the era of direct-acting antivirals? PLoS One 2019;14:e0211795. [PMID: 30753207 DOI: 10.1371/journal.pone.0211795] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Hayes B, Briceno A, Asher A, Yu M, Evans JL, Hahn JA, Page K. Preference, acceptability and implications of the rapid hepatitis C screening test among high-risk young people who inject drugs. BMC Public Health 2014;14:645. [PMID: 24965699 DOI: 10.1186/1471-2458-14-645] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
20 Ghany MG, Morgan TR;  AASLD-IDSA Hepatitis C Guidance Panel. Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Hepatology. 2020;71:686-721. [PMID: 31816111 DOI: 10.1002/hep.31060] [Cited by in Crossref: 145] [Cited by in F6Publishing: 133] [Article Influence: 72.5] [Reference Citation Analysis]
21 DeWeerdt S. Diagnostics: a testing journey. Nature 2011;474:S20-1. [PMID: 21666732 DOI: 10.1038/474S20a] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
22 Mahboobi N, Porter SR, Karayiannis P, Alavian SM. Oral fluid and hepatitis A, B and C: a literature review. J Oral Pathol Med. 2012;41:505-516. [PMID: 22188507 DOI: 10.1111/j.1600-0714.2011.01123.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
23 Manns MP, Buti M, Gane E, Pawlotsky JM, Razavi H, Terrault N, Younossi Z. Hepatitis C virus infection. Nat Rev Dis Primers. 2017;3:17006. [PMID: 28252637 DOI: 10.1038/nrdp.2017.6] [Cited by in Crossref: 189] [Cited by in F6Publishing: 162] [Article Influence: 37.8] [Reference Citation Analysis]
24 Puchades Renau L, Berenguer M. Introduction to hepatitis C virus infection: Overview and history of hepatitis C virus therapies: Overview and history of hepatitis C therapies. Hemodialysis International 2018;22:S8-S21. [DOI: 10.1111/hdi.12647] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
25 Vine LJ, Sieberhagen C, Cramp ME. Diagnosis and management of hepatitis C. Br J Hosp Med (Lond) 2015;76:625-30. [PMID: 26551491 DOI: 10.12968/hmed.2015.76.11.625] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
26 Tucker JD, Bien CH, Peeling RW. Point-of-care testing for sexually transmitted infections: recent advances and implications for disease control. Curr Opin Infect Dis 2013;26:73-9. [PMID: 23242343 DOI: 10.1097/QCO.0b013e32835c21b0] [Cited by in Crossref: 102] [Cited by in F6Publishing: 57] [Article Influence: 11.3] [Reference Citation Analysis]
27 Gao F, Talbot EA, Loring CH, Power JJ, Dionne-Odom J, Alroy-Preis S, Jackson P, Bean CL. Performance of the OraQuick HCV rapid antibody test for screening exposed patients in a hepatitis C outbreak investigation. J Clin Microbiol 2014;52:2650-2. [PMID: 24789176 DOI: 10.1128/JCM.00132-14] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
28 Lloyd YM, Esemu LF, Antallan J, Thomas B, Tassi Yunga S, Obase B, Christine N, Leke RGF, Culleton R, Mfuh KO, Nerurkar VR, Taylor DW. PCR-based detection of Plasmodium falciparum in saliva using mitochondrial cox3 and varATS primers. Trop Med Health 2018;46:22. [PMID: 29977122 DOI: 10.1186/s41182-018-0100-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
29 Carvalho-Gomes Â, Cubells A, Pallarés C, Hontangas V, Conde I, Di Maira T, Peiró S, Sanfélix-Gimeno G, López-Labrador FX, Berenguer M. A population-based screening for hepatitis C antibodies and active infection using a point-of-care test in a low prevalence area. PLoS One 2020;15:e0228351. [PMID: 32045417 DOI: 10.1371/journal.pone.0228351] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
30 Cruz HM, Marques VA, Villela-Nogueira CA, do Ó KM, Lewis-Ximenez LL, Lampe E, Villar LM. An evaluation of different saliva collection methods for detection of antibodies against hepatitis C virus (anti-HCV). J Oral Pathol Med. 2012;41:793-800. [PMID: 22690929 DOI: 10.1111/j.1600-0714.2012.01176.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
31 O'Leary JG, Neri MA, Trotter JF, Davis GL, Klintmalm GB. Utilization of hepatitis C antibody-positive livers: genotype dominance is virally determined. Transpl Int 2012;25:825-9. [PMID: 22643162 DOI: 10.1111/j.1432-2277.2012.01498.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
32 Cowan E, Herman HS, Rahman S, Zahn J, Leider J, Calderon Y. Bundled HIV and Hepatitis C Testing in the Emergency Department: A Randomized Controlled Trial. West J Emerg Med 2018;19:1049-56. [PMID: 30429941 DOI: 10.5811/westjem.2018.8.37827] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
33 Hagen RM, Wulff B, Loderstaedt U, Fengler I, Frickmann H, Schwarz NG, Polywka S. Is rapid hepatitis C virus testing from corpses a screening option for index persons who have died after mass-casualty incidents in high-prevalence settings in the field? J R Army Med Corps 2014;160:226-31. [PMID: 24113204 DOI: 10.1136/jramc-2013-000133] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
34 Larrat S, Bourdon C, Baccard M, Garnaud C, Mathieu S, Quesada JL, Signori-Schmuck A, Germi R, Blanc M, Leclercq P. Performance of an antigen-antibody combined assay for hepatitis C virus testing without venipuncture. J Clin Virol. 2012;55:220-225. [PMID: 22901327 DOI: 10.1016/j.jcv.2012.07.016] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
35 Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines: management of hepatitis C. Clin Mol Hepatol 2014;20:89-136. [PMID: 25032178 DOI: 10.3350/cmh.2014.20.2.89] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
36 da Rosa L, Dantas-Corrêa EB, Narciso-Schiavon JL, Schiavon Lde L. Diagnostic Performance of Two Point-of-Care Tests for Anti-HCV Detection. Hepat Mon 2013;13:e12274. [PMID: 24282422 DOI: 10.5812/hepatmon.12274] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
37 Antipchik M, Polyakov D, Sinitsyna E, Dzhuzha A, Shavlovsky M, Korzhikova-Vlakh E, Tennikova T. Towards the Development of a 3-D Biochip for the Detection of Hepatitis C Virus. Sensors (Basel) 2020;20:E2719. [PMID: 32397590 DOI: 10.3390/s20092719] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
38 Khuroo MS, Khuroo NS, Khuroo MS. Diagnostic accuracy of point-of-care tests for hepatitis C virus infection: a systematic review and meta-analysis. PLoS One. 2015;10:e0121450. [PMID: 25816332 DOI: 10.1371/journal.pone.0121450] [Cited by in Crossref: 63] [Cited by in F6Publishing: 49] [Article Influence: 9.0] [Reference Citation Analysis]
39 Houri I, Horowitz N, Katchman H, Weksler Y, Miller O, Deutsch L, Shibolet O. Emergency department targeted screening for hepatitis C does not improve linkage to care. World J Gastroenterol 2020; 26(32): 4878-4888 [PMID: 32921964 DOI: 10.3748/wjg.v26.i32.4878] [Reference Citation Analysis]
40 Prabdial-Sing N, Gaelejwe L, Makhathini L, Thaver J, Manamela MJ, Malfeld S, Spearman CW, Sonderup M, Scheibe A, Young K, Hausler H, Puren AJ. The performance of hepatitis C virus (HCV) antibody point-of-care tests on oral fluid or whole blood and dried blood spot testing for HCV serology and viral load among individuals at higher risk for HCV in South Africa. Health Sci Rep 2021;4:e229. [PMID: 33614978 DOI: 10.1002/hsr2.229] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Narayanamurthy V, Jeroish ZE, Bhuvaneshwari KS, Samsuri F. Hepatitis C virus (HCV) diagnosis via microfluidics. Anal Methods 2021;13:740-63. [PMID: 33511975 DOI: 10.1039/d0ay02045a] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Pallarés C, Carvalho-Gomes Â, Hontangas V, Conde I, Di Maira T, Aguilera V, Benlloch S, Berenguer M, López-Labrador FX. Performance of the OraQuick Hepatitis C virus antibody test in oral fluid and fingerstick blood before and after treatment-induced viral clearance. J Clin Virol 2018;102:77-83. [PMID: 29525634 DOI: 10.1016/j.jcv.2018.02.016] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
43 Vetter BN, Ongarello S, Tyshkovskiy A, Alkhazashvili M, Chitadze N, Choun K, Sokkab A, De Weggheleire A, Vanroye F, Reipold EI. Sensitivity and specificity of rapid hepatitis C antibody assays in freshly collected whole blood, plasma and serum samples: A multicentre prospective study. PLoS One 2020;15:e0243040. [PMID: 33270716 DOI: 10.1371/journal.pone.0243040] [Reference Citation Analysis]
44 Tang W, Chen W, Amini A, Boeras D, Falconer J, Kelly H, Peeling R, Varsaneux O, Tucker JD, Easterbrook P. Diagnostic accuracy of tests to detect Hepatitis C antibody: a meta-analysis and review of the literature. BMC Infect Dis 2017;17:695. [PMID: 29143615 DOI: 10.1186/s12879-017-2773-2] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 10.2] [Reference Citation Analysis]
45 Butler EK, McCullough J. Pathogen reduction combined with rapid diagnostic tests to reduce the risk of transfusion-transmitted infections in Uganda. Transfusion 2018;58:854-61. [PMID: 29405306 DOI: 10.1111/trf.14497] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
46 Fisher DG, Hess KL, Erlyana E, Reynolds GL, Cummins CA, Alonzo TA. Comparison of Rapid Point-of-Care Tests for Detection of Antibodies to Hepatitis C Virus. Open Forum Infect Dis 2015;2:ofv101. [PMID: 26269795 DOI: 10.1093/ofid/ofv101] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
47 Cha YJ, Park Q, Kang ES, Yoo BC, Park KU, Kim JW, Hwang YS, Kim MH. Performance evaluation of the OraQuick hepatitis C virus rapid antibody test. Ann Lab Med. 2013;33:184-189. [PMID: 23667844 DOI: 10.3343/alm.2013.33.3.184] [Cited by in Crossref: 54] [Cited by in F6Publishing: 44] [Article Influence: 6.0] [Reference Citation Analysis]
48 Candfield S, Samuel MI, Ritchie D, McDonald C, Brady M, Taylor C. Use and acceptability of salivary hepatitis C virus testing in an English Young Offender Institution. Int J STD AIDS 2017;28:1234-8. [PMID: 28632479 DOI: 10.1177/0956462417696214] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
49 Corstjens PL, Abrams WR, Malamud D. Saliva and viral infections. Periodontol 2000 2016;70:93-110. [PMID: 26662485 DOI: 10.1111/prd.12112] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 8.8] [Reference Citation Analysis]
50 Korean Association for the Study of the Liver. KASL clinical practice guidelines: management of hepatitis C. Clin Mol Hepatol. 2016;22:76-139. [PMID: 27044763 DOI: 10.3350/cmh.2016.22.1.76] [Cited by in Crossref: 42] [Cited by in F6Publishing: 52] [Article Influence: 7.0] [Reference Citation Analysis]
51 Attallah AM, Omran MM, Nasif WA, Ghaly MF, El-shanshoury AER, Abdalla MS, Sharada HM, Farid K, El-shony W, Moussa EM, El-domany EB, Nour E, Eldosoky I. Diagnostic Performances of Hepatitis C Virus-NS4 Antigen in Patients with Different Liver Pathologies. Archives of Medical Research 2012;43:555-62. [DOI: 10.1016/j.arcmed.2012.09.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
52 Andries AC, Duong V, Ong S, Ros S, Sakuntabhai A, Horwood P, Dussart P, Buchy P. Evaluation of the performances of six commercial kits designed for dengue NS1 and anti-dengue IgM, IgG and IgA detection in urine and saliva clinical specimens. BMC Infect Dis 2016;16:201. [PMID: 27184801 DOI: 10.1186/s12879-016-1551-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
53 Park SH, Bang CS, Kim DJ. Biomarkers in HCV Infection. Adv Clin Chem 2015;70:131-96. [PMID: 26231487 DOI: 10.1016/bs.acc.2015.03.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
54 Saab S, Viramontes MR, Chalifoux SL, Craw CJ, Ramirez SD, Bau SN, Arevalo DG, Saab EG, Saab CE, Craw CS, Estafanous A, Messiah R, Messiah W, El Kabany M. Hepatitis C Virus Prevalence in Egyptian Americans in Southern California. J Clin Gastroenterol 2018;52:55-9. [PMID: 28617761 DOI: 10.1097/MCG.0000000000000858] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
55 Mangia A, Rina MF, Canosa A, Piazzolla V, Squillante MM, Agostinacchio E, Cocomazzi G, Visaggi E, Augello N, Iannuzziello C, Falcone M, De Giorgi A, Campanozzi F. Increased Hepatitis C virus screening, diagnosis and linkage to care rates among people who use drugs through a patient-centered program from Italy. United European Gastroenterol J 2021;9:1109-18. [PMID: 34697911 DOI: 10.1002/ueg2.12156] [Reference Citation Analysis]
56 Lee J, Lee JB, Song HY, Son MJ, Li L, Rhyu IC, Lee YM, Koo KT, An JS, Kim JS, Kim E. Diagnostic Models for Screening of Periodontitis with Inflammatory Mediators and Microbial Profiles in Saliva. Diagnostics (Basel) 2020;10:E820. [PMID: 33066545 DOI: 10.3390/diagnostics10100820] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
57 Sauer-Budge AF, Brookfield SJ, Janzen R, McGray S, Boardman A, Wirz H, Pollock NR. A novel device for collecting and dispensing fingerstick blood for point of care testing. PLoS One 2017;12:e0183625. [PMID: 28837616 DOI: 10.1371/journal.pone.0183625] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
58 Gajardo P, Riquelme V, Vicencio D. Optimal Control of Diseases in Prison Populations through Screening Policies of New Inmates. SIAM J Control Optim . [DOI: 10.1137/20m1378582] [Reference Citation Analysis]
59 Meyer T, Schüttler CG, Straube E, Roß RS, Stürmer M, Jansen K, Buder S, Nick S, Hagedorn H, Bremer V, Brockmeyer NH. Schnelltest-Diagnostik sexuell übertragbarer Infektionen in niedrigschwelligen Einrichtungen: Gemeinsame Stellungnahme des RKI, PEI und der DSTIG. Bundesgesundheitsbl 2017;60:245-54. [DOI: 10.1007/s00103-016-2496-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
60 Li HC, Lo SY. Hepatitis C virus: Virology, diagnosis and treatment. World J Hepatol 2015; 7(10): 1377-1389 [PMID: 26052383 DOI: 10.4254/wjh.v7.i10.1377] [Cited by in Crossref: 76] [Cited by in F6Publishing: 52] [Article Influence: 10.9] [Reference Citation Analysis]
61 Scalioni Lde P, Cruz HM, de Paula VS, Miguel JC, Marques VA, Villela-Nogueira CA, Milagres FA, Cruz MS, Bastos FI, Andrade TM. Performance of rapid hepatitis C virus antibody assays among high- and low-risk populations. J Clin Virol. 2014;60:200-205. [PMID: 24794796 DOI: 10.1016/j.jcv.2014.04.001] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
62 Mbanya D. Use of quality rapid diagnostic testing for safe blood transfusion in resource-limited settings. Clin Microbiol Infect 2013;19:416-21. [PMID: 23464853 DOI: 10.1111/1469-0691.12184] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
63 Visseaux B, Larrouy L, Calin R, Katlama C, Poynard T, Ratziu V, Thibault V. Anti-hepatitis C virus antibody detection in oral fluid: Influence of human immunodeficiency virus co-infection. Journal of Clinical Virology 2013;58:385-90. [DOI: 10.1016/j.jcv.2013.07.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
64 Ndako JA, Owolabi AO, Olisa JA, Akinwumi JA, Dojumo VT, Olatinsu O, Adebayo BA. Studies on the prevalence of Hepatitis C virus infection in diabetic patients attending a tertiary health-care facility South-west Nigeria. BMC Infect Dis 2020;20:664. [PMID: 32907538 DOI: 10.1186/s12879-020-05388-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Warkad SD, Song KS, Pal D, Nimse SB. Developments in the HCV Screening Technologies Based on the Detection of Antigens and Antibodies. Sensors (Basel) 2019;19:E4257. [PMID: 31575036 DOI: 10.3390/s19194257] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
66 Easterbrook PJ; WHO Guidelines Development Group. Who to test and how to test for chronic hepatitis C infection - 2016 WHO testing guidance for low- and middle-income countries. J Hepatol 2016;65:S46-66. [PMID: 27641988 DOI: 10.1016/j.jhep.2016.08.002] [Cited by in Crossref: 66] [Cited by in F6Publishing: 59] [Article Influence: 16.5] [Reference Citation Analysis]
67 Saludes V, González V, Planas R, Matas L, Ausina V, Martró E. Tools for the diagnosis of hepatitis C virus infection and hepatic fibrosis staging. World J Gastroenterol 2014; 20(13): 3431-3442 [PMID: 24707126 DOI: 10.3748/wjg.v20.i13.3431] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
68 Liu L, Zhang M, Hang L, Kong F, Yan H, Zhang Y, Feng X, Gao Y, Wang C, Ma H, Liu X, Zhan M, Pan Y, Xu H, Niu J. Evaluation of a new point-of-care oral anti-HCV test for screening of hepatitis C virus infection. Virol J 2020;17:14. [PMID: 32005264 DOI: 10.1186/s12985-020-1293-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
69 Kant J, Möller B, Heyne R, Herber A, Böhm S, Maier M, Liebert UG, Mössner J, Berg T, Wiegand J. Evaluation of a rapid on-site anti-HCV test as a screening tool for hepatitis C virus infection. Eur J Gastroenterol Hepatol. 2013;25:416-420. [PMID: 23211286 DOI: 10.1097/meg.0b013e32835c502d] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
70 Prasidthrathsint K, Stapleton JT. Laboratory Diagnosis and Monitoring of Viral Hepatitis. Gastroenterol Clin North Am. 2019;48:259-279. [PMID: 31046974 DOI: 10.1016/j.gtc.2019.02.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
71 Drobnik A, Judd C, Banach D, Egger J, Konty K, Rude E. Public health implications of rapid hepatitis C screening with an oral swab for community-based organizations serving high-risk populations. Am J Public Health 2011;101:2151-5. [PMID: 21940910 DOI: 10.2105/AJPH.2011.300251] [Cited by in Crossref: 56] [Cited by in F6Publishing: 29] [Article Influence: 5.1] [Reference Citation Analysis]
72 Hønge B, Jespersen S, Medina C, Té D, da Silva Z, Ostergaard L, Laursen A, Wejse C, Krarup H, Erikstrup C; Bissau HIV cohort study group. Hepatitis B virus surface antigen and anti-hepatitis C virus rapid tests underestimate hepatitis prevalence among HIV-infected patients. HIV Med 2014;15:571-6. [PMID: 24717010 DOI: 10.1111/hiv.12158] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
73 Peaper DR, Landry ML. Laboratory diagnosis of viral infection. Handb Clin Neurol 2014;123:123-47. [PMID: 25015483 DOI: 10.1016/B978-0-444-53488-0.00005-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
74 Clerc O, Darling K, Calmy A, Dubois-arber F, Cavassini M. Hepatitis C Virus Awareness Among Men Who Have Sex With Men in Southwest Switzerland. Sexually Transmitted Diseases 2016;43:44-8. [DOI: 10.1097/olq.0000000000000378] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]